Pathology: mBC - TNBC - L1 - all population;
mBC - TNBC - L1 - all population | |||
IMpassion-130 (all population), 2018 | IMpassion-131 (all population), 2020 | ||
atezolizumab plus paclitaxel | 1 | T1 | |
atezolizumab plus nab-paclitaxel | 1 | T1 | |
Standard of Care (SoC) | 0 | T0 | T0 |